# An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain

> **NCT01914666** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 151 (actual)

## Conditions studied

- Back Pain Lower Back Chronic

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT01914666
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2016-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01914666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01914666, "An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01914666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*